Verastem reported $188.6M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Alaunos Therapeutics USD 7M 2M Mar/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
Curis USD 22M 9M Mar/2026
Cytokinetics USD 11.55B 3.36B Jun/2026
Gilead Sciences USD 156.86B 16.13B Jun/2026
Incyte USD 22.65B 3.92B Jun/2026
Laboratory Of America USD 22.96B 1.03B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026
Verastem USD 466M 130M Mar/2026